SSTR3: GPCR Involved in Various Physiological Processes and Potential Drug Target

Target Name: SSTR3

NCBI ID: G6753

SSTR3

Other Name(s): Somatostatin receptor type 3 | SS3-R | Sst3 | SSR3_HUMAN | Somatostatin receptor 3, transcript variant 1 | Somatostatin receptor 3 | SS-3-R | SSR-28 | somatostatin receptor 3 | SST3 | Somatostatin SRIF1C (SS3R) receptor | SSTR3 variant 1 | SS3R

SSTR3: GPCR Involved in Various Physiological Processes and Potential Drug Target

SSTR3, or Somatostatin receptor type 3, is a protein that is expressed in various tissues throughout the body. It is a G protein-coupled receptor (GPCR), which means it is a transmembrane protein that spans the cell membrane and is involved in intracellular signaling. SSTR3 is one of a family of GPCRs that are involved in the regulation of various physiological processes in the body, including cell growth, differentiation, and metabolism.

SSTR3 is involved in the regulation of several key processes in the body, including:

1. Cell growth and differentiation: SSTR3 is involved in the regulation of cell growth and differentiation, and it is thought to play a role in the development and maintenance of tissues such as muscle, bone, and skin.
2. Metabolism: SSTR3 is involved in the regulation of metabolism, including the production and breakdown of tissues.
3. Pain perception: SSTR3 is involved in the perception of pain, and it is thought to play a role in the regulation of pain sensitivity.
4. Neurodegenerative diseases: SSTR3 is involved in the regulation of several neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease.

SSTR3 is also a potential drug target, or biomarker, for several diseases. For example, inhibition of SSTR3 has been shown to be effective in treating neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease. Additionally, SSTR3 is also thought to be involved in the regulation of cancer cell growth, and inhibition of SSTR3 has been shown to be effective in treating certain types of cancer.

In conclusion, SSTR3 is a protein that is involved in the regulation of various physiological processes in the body. It is a GPCR that is expressed in various tissues throughout the body and is thought to play a role in the development and maintenance of tissues, including muscle, bone, and skin. SSTR3 is also involved in the regulation of metabolism, pain perception, and neurodegenerative diseases, and it is a potential drug target or biomarker for several diseases. Further research is needed to fully understand the role of SSTR3 in the regulation of these processes and its potential as a drug.

Protein Name: Somatostatin Receptor 3

Functions: Receptor for somatostatin-14 and -28. This receptor is coupled via pertussis toxin sensitive G proteins to inhibition of adenylyl cyclase

The "SSTR3 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SSTR3 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets